ImmunoGen Inc (IMGN)

[skitahoe]

It will be converted to cash in your account at a rate of $31.26 per share.

After all these years IMGN is gone as an investment, but will be operating as a subsidiary of ABBV. It's not impossible that at some date in the future ABBV could spin off IMGN, while no doubt holding a controlling interest. That's a tact that Roche has used before and certainly could be by ABBV if they wished to raise some money in that way. It would be a very different company if that ever occurred.

For now, I do hope we share ideas here on other investments we're putting the money into.

Gary